By investigating the
in vitroactivity of 21 antimicrobial agents that are commonly available for veterinary use against 303 Japanese isoletes of
Actinobacillus pleuropneumoniaecollected between 1986-1987 (178 strains) and 1999-2000 (125 strains), the authors compared the susceptibility of strains isolated in different years to the drugs examined. The resistant frequencies of the recent isolates were increased in (P<0.01, χ
2test): PCG (change of resistance rate: 1.1%→13.6%), AMPC (1.1%→12.0%), ASPC (1.1%→12.0%), OTC (5.6%→44.8%), CP (1.1%→27.2%) and TP (1.7%→30.4%), which are used mainly for the treatment of disease caused by
Actinobacillus pleuropneumoniae. In addition, among recent isolates, two of 24 strains typed into serotype 1 were resistant to fluoroquinolones, and one of 76 strains of serotype 2 was resistant to macrolides. Most of the recent isolates were highly susceptible to CTF, FF and fluoroquinolones.
View full abstract